Company profile
HCW Biologics Inc.
NASDAQ:HCWBBiotechnology: Pharmaceutical Preparations
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT07049328 | phase1 | recruiting | 2025-08-16 | 2027-07-16 | HCW Biologics | HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata |
FDA applications (0)
No records yet.